we conducted a randomized , double-blind , placebo-controlled clinical trial of recombinant human erythropoietin ( 100 u per kilogram of body weight thrice weekly by intravenous bolus ) in 63 patients with aids treated with zidovudine ( 29 in the erythropoietin group and 34 in the placebo group ) .
C0001175
aids
C0043474
zidovudine